Nanosonics Reports Low ROCE of 7.7%, Market Confidence Wanes
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 05 2026
0mins
Should l Buy NAN?
Source: Yahoo Finance
- ROCE Analysis: Nanosonics reports a Return on Capital Employed (ROCE) of 7.7%, which is significantly below the medical equipment industry average of 10%, indicating inefficiencies in capital utilization that may hinder future investment appeal.
- Capital Investment Trend: Over the past five years, Nanosonics has increased its capital employed by 80%, yet the ROCE has remained stable, suggesting that the company is not effectively deploying new capital into high-return investments, which could lead to declining market confidence.
- Poor Market Performance: The stock has plummeted by 48% over the last five years, reflecting investor pessimism regarding the company's growth potential and exacerbating doubts about its business model.
- Investment Opportunity Assessment: While Nanosonics is reinvesting in its operations, its low return rates and poor market performance make the search for alternative multi-bagger opportunities more urgent, prompting investors to carefully evaluate its intrinsic value.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NAN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NAN
Wall Street analysts forecast NAN stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 11.465
Low
Averages
High
Current: 11.465
Low
Averages
High
About NAN
Nuveen New York Quality Municipal Income Fund (the Fund) is a diversified, closed-end management investment fund. The Fund’s investment objective is to provide current income exempt from regular federal, and New York State and New York City income tax and to enhance portfolio value. The Fund invests in municipal securities that are exempt from federal, New York state, and New York City income taxes. The Fund invests at least 80% of its managed assets in securities rated, at the time of investment, investment grade or, if they are unrated, are judged by the manager to be of comparable quality. The Fund may invest up to 20% of its managed assets in municipal securities rated below investment quality or judged by the manager to be of comparable quality. The Fund invests in various sectors, such as consumer staples, health care, transportation, and utilities. The Funds’ investment adviser is Nuveen Fund Advisors, LLC.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Top Growth Companies in Australia with High Insider Ownership
- High Insider Ownership Attracts Attention: Amid global economic fluctuations, Australian companies with high insider ownership, such as Torque Metals (18.5%) and Magnetic Resources (33.6%), demonstrate strong growth potential with earnings growth of 94.2% and 124.2%, respectively, drawing investor interest to navigate uncertainties.
- Growth Potential of Kogan.com: Kogan.com boasts 22.3% insider ownership with a projected annual earnings growth of 54.1%, generating A$371.62 million from its Australian online retail operations, indicating robust market performance and confidence in future growth.
- Market Expansion for Nanosonics: Nanosonics, with 15.6% insider ownership, anticipates a 21.2% annual earnings growth, generating A$207.26 million from its healthcare equipment segment, and a recent national purchasing agreement enhances its market reach and operational efficiency.
- Strategic Direction of PWR Holdings: PWR Holdings has 13.3% insider ownership and is expected to see a 28.6% annual earnings growth, with revenue growth projected at 12.4%, while recent board appointments may bolster governance and strategic direction despite a decline in profit margins.
See More
Nanosonics Reports Low ROCE of 7.7%, Market Confidence Wanes
- ROCE Analysis: Nanosonics reports a Return on Capital Employed (ROCE) of 7.7%, which is significantly below the medical equipment industry average of 10%, indicating inefficiencies in capital utilization that may hinder future investment appeal.
- Capital Investment Trend: Over the past five years, Nanosonics has increased its capital employed by 80%, yet the ROCE has remained stable, suggesting that the company is not effectively deploying new capital into high-return investments, which could lead to declining market confidence.
- Poor Market Performance: The stock has plummeted by 48% over the last five years, reflecting investor pessimism regarding the company's growth potential and exacerbating doubts about its business model.
- Investment Opportunity Assessment: While Nanosonics is reinvesting in its operations, its low return rates and poor market performance make the search for alternative multi-bagger opportunities more urgent, prompting investors to carefully evaluate its intrinsic value.
See More
Top Growth Companies in Australia with High Insider Ownership
- High Insider Ownership Attracts Attention: Amid global economic fluctuations, Australian companies with high insider ownership, such as Torque Metals (18.5%) and Magnetic Resources (33.6%), demonstrate strong growth potential with earnings growth of 94.2% and 124.2%, respectively, drawing investor interest to navigate uncertainties.
- Growth Potential of Kogan.com: Kogan.com boasts 22.3% insider ownership with a projected annual earnings growth of 54.1%, generating A$371.62 million from its Australian online retail operations, indicating robust market performance and confidence in future growth.
- Market Expansion for Nanosonics: Nanosonics, with 15.6% insider ownership, anticipates a 21.2% annual earnings growth, generating A$207.26 million from its healthcare equipment segment, and a recent national purchasing agreement enhances its market reach and operational efficiency.
- Strategic Direction of PWR Holdings: PWR Holdings has 13.3% insider ownership and is expected to see a 28.6% annual earnings growth, with revenue growth projected at 12.4%, while recent board appointments may bolster governance and strategic direction despite a decline in profit margins.
See More
Nanosonics Reports Low ROCE of 7.7%, Market Confidence Wanes
- ROCE Analysis: Nanosonics reports a Return on Capital Employed (ROCE) of 7.7%, which is significantly below the medical equipment industry average of 10%, indicating inefficiencies in capital utilization that may hinder future investment appeal.
- Capital Investment Trend: Over the past five years, Nanosonics has increased its capital employed by 80%, yet the ROCE has remained stable, suggesting that the company is not effectively deploying new capital into high-return investments, which could lead to declining market confidence.
- Poor Market Performance: The stock has plummeted by 48% over the last five years, reflecting investor pessimism regarding the company's growth potential and exacerbating doubts about its business model.
- Investment Opportunity Assessment: While Nanosonics is reinvesting in its operations, its low return rates and poor market performance make the search for alternative multi-bagger opportunities more urgent, prompting investors to carefully evaluate its intrinsic value.
See More
